Drugs / Dendritic Cell Activated Lymphocyte
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT00038870 | Jan 2001 → Jan 2003 | acute myeloid leukemia, chronic myeloid leukemia | M.D. Anderson Cancer Center | Withdrawn | No outcome recorded Stop: Enrollment |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Dendritic Cell Activated Lymphocyte | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00038870 ↗ |
| Action | Deplete | “acquire leukemia specific cytotoxicity” NCT00038870 ↗ |
| Modality | Cell therapy | “these activated cells given after reinduction chemotherapy” NCT00038870 ↗ |